Previous close | 2.2100 |
Open | 2.2100 |
Bid | 1.7900 |
Ask | 2.6600 |
Strike | 3.00 |
Expiry date | 2024-01-19 |
Day's range | 2.2100 - 2.2100 |
Contract range | N/A |
Volume | |
Open interest | 161 |
Marks 29 Patents Worldwide Directed to Biora’s Device Localization TechnologySAN DIEGO, May 19, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today announced a new patent related to its Drug Delivery System (DDS) platform under development. The USPTO has issued U.S. Patent No. 10,835,152 entitled, “Electromechanical pill device with localization capabilities” and allowed U.S. Application No. 15/940,407 entitled, “Localizat
SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today announced that the Company’s management team will be presenting a corporate overview and participating in one-on-one meetings, upon request, with conference attendees at the upcoming H.C. Wainwright Global Investment Conference, which is taking place both virtually and in-person at the Fontainebleau Hotel in Miami, Florida, May 23 to 26, 2022. H.C. Wain
Completed transformation with the launch of Biora Therapeutics to reflect the company’s focus on oral therapeutic solutions Successfully transferred its single-molecule detection platform with launch of Enumera Molecular Strengthened therapeutics capability and leadership with addition of Paul Shabram and opening of operations lab space Management will host conference call and webcast today at 4:30 p.m. Eastern / 1:30 p.m. Pacific SAN DIEGO, May 10, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, I